-
Mar 2011
An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells.
Genes ImmunLong SA, Cerosaletti K, Wan JY, Ho JC, Tatum M, Wei S, Shilling HG, Buckner JH -
Feb 2011
Phenotypical and functional specialization of FOXP3+ regulatory T cells.
Nat Rev ImmunolCampbell DJ, Koch MA -
Feb 2011
Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
HepatologyLonghi MS, Hussain MJ, Kwok WW, Mieli-Vergani G, Ma Y, Vergani D -
Jan 2011
Common variants in P2RY11 are associated with narcolepsy.
Nat GenetKornum BR, Kawashima M, Faraco J, Lin L, Rico TJ, Hesselson S, Axtell RC, Kuipers H, Weiner K, Hamacher A, Kassack MU, Han F, Knudsen S, Li J, Dong X, Winkelmann J, Plazzi G, Nevsimalova S, Hong SC, Honda Y, Honda M, Högl B, Ton TG, Montplaisir J, Bourgin P, Kemlink D, Huang YS, Warby S, Einen M, Eshragh JL, Miyagawa T, Desautels A, Ruppert E, Hesla PE, Poli F, Pizza F, Frauscher B, Jeong JH, Lee SP, Strohl KP, Longstreth WT Jr, Kvale M, Dobrovolná M, Ohayon MM, Nepom GT, Wichmann HE, Rouleau GA, Gieger C, Levinson DF, Gejman PV, Meitinger T, Peppard P, Young T, Jennum P, Steinman L, Tokunaga K, Kwok PY, Risch N, Hallmayer J, Mignot E -
Jan 2011
Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes.
PLoS OneLachin JM, McGee PL, Greenbaum CJ, Palmer JP, Pescovitz MD, Gottlieb PA, Skyler JS, Type 1 Diabetes Trial Network -
Jan 2011
Assessment of suppressive capacity by human regulatory T cells using a reproducible, bi-directional CFSE-based in vitro assay.
Methods Mol BiolSchneider A, Buckner JH -
Dec 2010
Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.
Int J CardiolChung IM, Kim J, Pak YK, Jang Y, Yang WI, Han I, Park SJ, Park SW, Huh J, Wight TN, Ueno H -
Dec 2010
Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.
Nat Rev ImmunolBuckner JH -
Dec 2010
Innate signals from Nod2 block respiratory tolerance and program T(H)2-driven allergic inflammation.
J Allergy Clin ImmunolDuan W, Mehta AK, Magalhaes JG, Ziegler SF, Dong C, Philpott DJ, Croft M -
Dec 2010
The role of thymic stromal lymphopoietin (TSLP) in allergic disorders.
Curr Opin ImmunolZiegler SF -
Nov 2010
Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro.
J Biomed Mater Res ABota PC, Collie AM, Puolakkainen P, Vernon RB, Sage EH, Ratner BD, Stayton PS -
Nov 2010
A model for harmonizing flow cytometry in clinical trials.
Nat ImmunolMaecker HT, McCoy JP Jr, FOCIS Human Immunophenotyping Consortium., Amos M, Elliott J, Gaigalas A, Wang L, Aranda R, Banchereau J, Boshoff C, Braun J, Korin Y, Reed E, Cho J, Hafler D, Davis M, Fathman CG, Robinson W, Denny T, Weinhold K, Desai B, Diamond B, Gregersen P, Di Meglio P, Nestle FO, Peakman M, Villanova F, Ferbas J, Field E, Kantor A, Kawabata T, Komocsar W, Lotze M, Nepom J, Ochs H, O'Lone R, Phippard D, Plevy S, Rich S, Roederer M, Rotrosen D, Yeh JH, Nepom GT -
Nov 2010
The Immune Tolerance Network at 10 years: tolerance research at the bedside.
Nat Rev ImmunolBluestone JA, Auchincloss H, Nepom GT, Rotrosen D, St Clair EW, Turka LA -
Nov 2010
Thymic stromal lymphopoietin contributes to myeloid hyperplasia and increased immunoglobulins, but not epidermal hyperplasia, in RabGEF1-deficient mice.
Am J PatholTsai M, Chen CC, Mukai K, Song CH, Thompson LJ, Ziegler SF, Tam SY, Galli SJ -
Nov 2010
Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging.
Arterioscler Thromb Vasc BiolOlive M, Harten I, Mitchell R, Beers JK, Djabali K, Cao K, Erdos MR, Blair C, Funke B, Smoot L, Gerhard-Herman M, Machan JT, Kutys R, Virmani R, Collins FS, Wight TN, Nabel EG, Gordon LB
